A detailed history of Victory Capital Management Inc transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Victory Capital Management Inc holds 17,200 shares of OCUL stock, worth $167,700. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,200
Previous 17,403 1.17%
Holding current value
$167,700
Previous $119,000 25.21%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$6.45 - $9.23 $1,309 - $1,873
-203 Reduced 1.17%
17,200 $149,000
Q2 2024

Aug 05, 2024

BUY
$4.2 - $8.69 $19,719 - $40,799
4,695 Added 36.95%
17,403 $119,000
Q1 2024

May 03, 2024

BUY
$3.85 - $10.93 $9,906 - $28,122
2,573 Added 25.39%
12,708 $115,000
Q4 2023

Feb 05, 2024

BUY
$2.08 - $4.52 $21,080 - $45,810
10,135 New
10,135 $45,000
Q2 2022

Aug 01, 2022

SELL
$3.01 - $5.22 $150 - $261
-50 Reduced 0.49%
10,137 $41,000
Q1 2022

May 04, 2022

SELL
$4.83 - $7.35 $1,395 - $2,124
-289 Reduced 2.76%
10,187 $36,000
Q4 2021

Feb 07, 2022

SELL
$6.16 - $12.07 $1,989 - $3,898
-323 Reduced 2.99%
10,476 $73,000
Q3 2021

Nov 02, 2021

SELL
$9.7 - $14.34 $3,695 - $5,463
-381 Reduced 3.41%
10,799 $108,000
Q2 2021

Aug 03, 2021

SELL
$13.43 - $19.16 $20.6 Million - $29.5 Million
-1,537,447 Reduced 99.28%
11,180 $159,000
Q1 2021

May 04, 2021

BUY
$15.82 - $22.11 $7.31 Million - $10.2 Million
461,855 Added 42.5%
1,548,627 $25.4 Million
Q4 2020

Feb 01, 2021

BUY
$7.91 - $22.95 $8.6 Million - $24.9 Million
1,086,772 New
1,086,772 $22.5 Million
Q2 2020

Aug 07, 2020

SELL
$4.67 - $8.95 $34,226 - $65,594
-7,329 Closed
0 $0
Q1 2020

May 04, 2020

SELL
$3.95 - $7.4 $319 - $599
-81 Reduced 1.09%
7,329 $36,000
Q4 2019

Feb 04, 2020

BUY
$2.57 - $4.73 $758 - $1,395
295 Added 4.15%
7,410 $32,000
Q3 2019

Nov 12, 2019

BUY
$3.04 - $5.32 $21,629 - $37,851
7,115 New
7,115 $22,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $750M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.